
ABEO Valuation
Abeona Therapeutics Inc
- Overview
- Forecast
- Valuation
- Earnings
ABEO Relative Valuation
ABEO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABEO is overvalued; if below, it's undervalued.
Historical Valuation
Abeona Therapeutics Inc (ABEO) is now in the Fair zone, suggesting that its current forward PS ratio of 4.66 is considered Fairly compared with the five-year average of 2.27. The fair price of Abeona Therapeutics Inc (ABEO) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:6.65
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
7.93
P/B
Median3y
3.13
Median5y
2.41
-18.89
FCF Yield
Median3y
-66.91
Median5y
-73.59
Competitors Valuation Multiple
The average P/S ratio for ABEO's competitors is 95.18, providing a benchmark for relative valuation. Abeona Therapeutics Inc Corp (ABEO) exhibits a P/S ratio of 4.66, which is -95.10% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

SVRE
Saverone 2014 Ltd
2.570
USD
-6.20%

VUZI
Vuzix Corp
2.330
USD
-3.32%

TVGN
Tevogen Bio Holdings Inc
1.070
USD
-0.93%

BPRN
Princeton Bancorp Inc
31.540
USD
-3.01%

RCEL
AVITA Medical Inc
5.980
USD
-4.47%

CHMG
Chemung Financial Corp
52.820
USD
-1.07%

ARAY
Accuray Inc
1.370
USD
-2.84%

KFS
Kingsway Financial Services Inc
14.400
USD
-0.96%

LAZR
Luminar Technologies Inc
3.390
USD
-10.32%

ELLO
Ellomay Capital Ltd
17.645
USD
-0.93%
FAQ

Is Abeona Therapeutics Inc (ABEO) currently overvalued or undervalued?
Abeona Therapeutics Inc (ABEO) is now in the Fair zone, suggesting that its current forward PS ratio of 4.66 is considered Fairly compared with the five-year average of 2.27. The fair price of Abeona Therapeutics Inc (ABEO) is between to according to relative valuation methord.

What is Abeona Therapeutics Inc (ABEO) fair value?

How does ABEO's valuation metrics compare to the industry average?

What is the current P/B ratio for Abeona Therapeutics Inc (ABEO) as of Jul 25 2025?

What is the current FCF Yield for Abeona Therapeutics Inc (ABEO) as of Jul 25 2025?

What is the current Forward P/E ratio for Abeona Therapeutics Inc (ABEO) as of Jul 25 2025?
